Citi Says Buy the Dip in Bristol-Myers (BMY) Shares

June 26, 2012 8:36 AM EDT
Get Alerts BMY Hot Sheet
Price: $56.07 -0.37%

Rating Summary:
    11 Buy, 11 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 5 | Down: 5 | New: 0
Trade BMY Now!
Join SI Premium – FREE
An analyst at Citi is recommending investors buy shares of Bristol-Myers Squibb (NYSE: BMY) following Monday's 3.5 percent decline on the heels of an FDA delay for ELIQUIS. The analyst said the delay is "not substantial."

The stock has not yet traded in Tuesday's pre-open session. Shares closed at $34.13 on the NYSE on Monday.

Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Bristol-Myers.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities


Add Your Comment